Difficulty: Medium
Average Score: 75%
Practice
ACE inhibitors:
Correct answer
D
Rationale
In the context of Advanced Pharmacology Across the Lifespan, understanding the mechanism of action of ACE inhibitors is crucial for safe and effective prescribing practices. The correct answer is D) decrease glomerular efferent arteriolar resistance. ACE inhibitors work by dilating both the afferent and efferent arterioles within the glomerulus, but predominantly affecting the efferent arteriole. By dilating the efferent arteriole, ACE inhibitors decrease glomerular efferent arteriolar resistance, leading to a reduction in glomerular filtration pressure and intraglomerular pressure. This mechanism is beneficial in conditions like hypertension and heart failure.
Option A) decrease levels of bradykinin is incorrect because ACE inhibitors actually increase levels of bradykinin by inhibiting its breakdown, which can lead to side effects like dry cough.
Option B) cause hyperkalaemia less often in patients with diabetes is incorrect. ACE inhibitors can actually increase the risk of hyperkalemia, especially in patients with diabetes or renal impairment, due to their effects on potassium excretion.
Option C) are contraindicated in patients on NSAIDs is incorrect. While there is a potential for interaction between ACE inhibitors and NSAIDs leading to decreased renal function, it is not an absolute contraindication. Close monitoring of renal function and hydration status is recommended if using both medications concurrently.
Understanding these nuances in the pharmacological actions of ACE inhibitors is essential for healthcare providers to make informed decisions when managing patients with various comorbidities and conditions.
Option A) decrease levels of bradykinin is incorrect because ACE inhibitors actually increase levels of bradykinin by inhibiting its breakdown, which can lead to side effects like dry cough.
Option B) cause hyperkalaemia less often in patients with diabetes is incorrect. ACE inhibitors can actually increase the risk of hyperkalemia, especially in patients with diabetes or renal impairment, due to their effects on potassium excretion.
Option C) are contraindicated in patients on NSAIDs is incorrect. While there is a potential for interaction between ACE inhibitors and NSAIDs leading to decreased renal function, it is not an absolute contraindication. Close monitoring of renal function and hydration status is recommended if using both medications concurrently.
Understanding these nuances in the pharmacological actions of ACE inhibitors is essential for healthcare providers to make informed decisions when managing patients with various comorbidities and conditions.